Answers are grounded in this paper and cite their sources.
Background Penicillin allergy labels (PAL) are reported in approximately 10% of the US population but reflect true IgE-mediated allergy in only 1–2%. PALs have been associated with broader-spectrum antibiotic use and adverse outcomes in general populations. The impact of PAL in people living with HIV (PWH) diagnosed with bacterial pneumonia has not been characterized. Methods A retrospective propensity score–matched cohort study was conducted using the TriNetX US Collaborative Network. Adults with HIV and a diagnosis of bacterial pneumonia were stratified by a documented PAL. 1:1 greedy nearest-neighbor matching balanced demographics, comorbidities, and CD4 strata. Antibiotic utilization at 30 days and clinical outcomes at 30 and 90 days were compared using risk ratios, Cox proportional-hazards models, and Kaplan–Meier survival analysis. Results After matching, PAL subjects had markedly lower penicillin exposure (11.8% vs. 26.4%; RR 0.45, p < 0.001) and significantly higher exposure to alternative antibiotics. At 30 days, PAL patients had increased risks for hospitalization (RR=1.205, 95%CI: 1.145-1.269) and intensive care services (RR=1.170, 95%CI: 1.004-1.365). At 90 days, higher rates of hospitalization (RR=1.195, 95%CI: 1.139-1.254), intensive care utilization (RR=1.352, 95%CI: 1.169-1.562), acute respiratory failure (RR=1.150, 95%CI: 1.043-1.267), mechanical ventilation (RR=1.227, 95%CI: 1.029-1.462), and acute kidney injury (RR=1.171, 95%CI: 1.030-1.332) were seen in the PAL group. Conclusions In PWH diagnosed with bacterial pneumonia, a PAL was associated with altered antibiotic prescribing and worse clinical outcomes, supporting proactive allergy delabeling as a high-yield stewardship intervention in HIV care.
No takes yet. Share an insight, caveat, or question.
Eby et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: